9IZM image
Deposition Date 2024-08-01
Release Date 2025-06-11
Last Version Date 2025-06-25
Entry Detail
PDB ID:
9IZM
Title:
Cryo-EM structure of CasLambda2-crRNA binary complex
Biological Source:
Source Organism:
unidentified (Taxon ID: 32644)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.02 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Cas Lambda2
Mutations:D324A
Chain IDs:A
Chain Length:751
Number of Molecules:1
Biological Source:unidentified
Polymer Type:polyribonucleotide
Molecule:RNA (58-MER)
Chain IDs:B
Chain Length:58
Number of Molecules:1
Biological Source:unidentified
Ligand Molecules
Primary Citation
Structural basis for target DNA cleavage and guide RNA processing by CRISPR-Cas lambda 2.
Commun Biol 8 876 876 (2025)
PMID: 40473912 DOI: 10.1038/s42003-025-08300-8

Abstact

RNA-guided CRISPR-Cas nucleases are widely used as versatile genome-engineering tools. Among the diverse CRISPR-Cas effectors, CRISPR-Casλ-also referred to as Cas12n-is a recently identified miniature type V nuclease encoded in phage genomes. Given its demonstrated nuclease activity in both mammalian and plant cells, Casλ has emerged as a promising candidate for genome-editing applications. However, the precise molecular mechanisms of Casλ family enzymes remain poorly understood. In this study, we report the identification and detailed biochemical and structural characterizations of CRISPR-Casλ2. The cryo-electron microscopy structures of Casλ2 in five different functional states unveiled the dynamic domain rearrangements during its activation. Our biochemical analyses indicated that Casλ2 processes its precursor crRNA to a mature crRNA using the RuvC active site through a unique ruler mechanism, in which Casλ2 defines the spacer length of the mature crRNA. Furthermore, structural comparisons of Casλ2 with Casλ1 and CasΦ highlighted the diversity and conservation of phage-encoded type V CRISPR-Cas enzymes. Collectively, our findings augment the mechanistic understanding of diverse CRISPR-Cas nucleases and establish a framework for rational engineering of the CRISPR-Casλ-based genome-editing platform.

Legend

Protein

Chemical

Disease

Primary Citation of related structures